
Join to View Full Profile
230 Nebraska StSioux City, IA 51101
Phone+1 712-252-0088
Fax+1 712-252-5271
Dr. Wender is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1984 - 1986
UPMC Medical EducationResidency, Internal Medicine, 1981 - 1984
Ohio State University College of MedicineClass of 1981
Certifications & Licensure
IA State Medical License 1986 - 2028
PA State Medical License 1982 - 1986
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2016-2017
Clinical Trials
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Start of enrollment: 2005 Apr 14
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
Publications & Presentations
PubMed
- 3 citationsCetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.Marla Lipsyc-Sharf, Fang-Shu Ou, Matthew B Yurgelun, Douglas A Rubinson, Deborah Schrag
The Oncologist. 2022-04-05 - 5 citationsPhase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.D J Inwards, P A Fishkin, B R LaPlant, M T Drake, P J Kurtin
Annals of Oncology. 2014-10-01 - 3 citationsAssessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1Lindsay C. Brown, Pamela J. Atherton, Michelle A. Neben-Wittich, Donald B. Wender, Robert J. Behrens
Supportive Care in Cancer. 2013-06-08
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









